STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
RGLS REGULUS THERAPEUTICS INCORPORATED StockScouter® Report
7
StockScouter® Score
REGULUS THERAPEUTICS INCORPORATED, a small cap company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is well above average. Positive
- Moving average analysis for RGLS suggests strong price movement over the medium term. Positive
Concerns
- The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
D
C
N/A
A